tetradecylthioacetic acid
Small moleculeexperimental
Tetradecylthioacetic acid (TTA) is a synthetic fatty acid used as a nutritional supplement. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2002 (NCT00605787)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCCCCCCCCCSCC(=O)O- Mol. weight
- 288.5 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTetradecylthioacetic acid ↗
- ChEMBLCHEMBL187734 ↗
Also known as
- 1-(carboxymethylthio)tetradecane
- 1-mono(carboxymethylthio)tetradecane
- cmtd
- tetradecylthioacetic acid
- tetradecylthioacetic acid
- tetradecylthioacetic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00605787 | Phase 2 | Jan 1, 2002 | University of Bergen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Bergen | Academic/Hospital | 1 | 1 | 1 | 2002 |
1 organizations
Page 1 / 1